Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Study protocol for a randomized controlled multinational trial to analyze the effects of an app-based patient education textbook (Ready4OP App) to increase health literacy before major oncologic surgery and its potential effects on surgical outcomes in Slovenia, Spain, and Germany—the APERIO Trial
Svenja Sliwinski; Franziska J. Stickl; S. Fatima Faqar-Uz-Zaman; Charlotte Detemble; Dora Zmuc; Jan Zmuc; Gasper Pilko; Cristina Dopazo; Maria Martinez-Lopez; Armin Wiegering; Andreas A. SchnitzbauerShow moreShow less
1. Department for General, Visceral, Transplant and Thoracic Surgery, Frankfurt University Hospital, Goethe University Frankfurt/Main, Frankfurt Am Main, Germany; 2. Klinik Für Chirurgie, Ruhr Universität Bochum, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany; 3. MCL Medical Center Ljubljana, Ljubljana, Slovenia; 4. Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; 5. Department of Hepatic and Biliary Surgery and Transplants, Vall d’Hebron Barcelona Hospital Campus, Barcelona, SpainShow moreShow less
Participation thresholds and recruitment milestones for HIV cure-related trials: a modified Delphi study
Ali Ahmed; Bridgette Picou; John A. Sauceda; Karine DubéShow moreShow less
1. Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, San Diego, USA; 2. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 3. The Well Project, Palm Springs, USA; 4. Division of Prevention Science, Department of Medicine, University of California, San Francisco, San Francisco, USAShow moreShow less
Evaluating the efficacy and safety of therapeutic plasma exchange in snakebite-associated thrombotic microangiopathy compared to standard care alone: study protocol for a multicenter randomized controlled trial
Eranga Wijewickrama; Bhawani Yasassri Alvitigala; Lallindra Gooneratne; Ariaranee Gnanathasan; Dilushi Wijayaratne; Upul Senarath; Anjana Silva; Rajitha Abeysekera; Geoffrey Isbister; Tina Noutsos; Indika GawarammanaShow moreShow less
1. Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; 2. Department of Pathology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; 3. Department of Community Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; 4. Department of Parasitology, Faculty of Medicine and Allied Health Sciences, Rajarata University, Mihintale, Sri Lanka; 5. Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka; 6. Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; 7. Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, AustraliaShow moreShow less
Whole-course care intervention for patients with spinal cord injury: study protocol for a randomized controlled trial
Peipei Ding; Haoran Li; Hui Huang; Mengmeng Chen; Xiaoxiao Xia; Linsheng Feng; Qing Dai; Lunlan LiShow moreShow less
1. Department of Nursing, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 2. School of Nursing, Anhui Medical University, Hefei, China; 3. Department of Nursing, The Second Hospital of Nanjing, Nanjing, China; 4. Orthopedics, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 5. Human Resources Department, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaShow moreShow less
Personalized assistive EMG-controlled virtual reality interface combined with cerebellar-iTBS for post-stroke arm recovery (ERICA): study protocol for a three-arm randomized controlled trial
Matteo Nocilli; Alex Martino Cinnera; Danny Adrian Spampinato; Valentina Pezzopane; Silvia Silella; Giacomo Koch; Andrea d’Avella; Denise Jennifer BergerShow moreShow less
1. Laboratory of Neuromotor Physiology, LIFE - Institute for Research and Care - Santa Lucia IRCCS, Rome, Italy; 2. Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 3. Experimental Neuropsychophysiology Lab, LIFE - Institute for Research and Care - Santa Lucia IRCCS, Rome, Italy; 4. Saint Camillus International University of Health and Medical Sciences (UniCamillus), Rome, Italy; 5. Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; 6. Center for Translational Neurophysiology of Speech and Communication, Italian Institute of Technology (IIT), Ferrara, Italy; 7. Department of Biology, University of Rome Tor Vergata, Rome, Italy; 8. Department of Systems Medicine, Centre of Space Bio-Medicine, University of Rome Tor Vergata, Rome, Italy; 9. Department of Theoretical and Applied Sciences, Research Centre for Applied Psychology, e-Campus University, Novedrate (Como), ItalyShow moreShow less
ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with A myotrophic lateral sclerosis for the evaluation of efficacy and safety of B - C ell D epletion with rituximab (ABCD)
Friederike Ufer; Rosa Rössling; Annika Spottke; Robert Németh; Tamara Schaprian; Nadja Kemmerling-de Coninck; Anna Gamez; Rebecca Sterl; Pia Naumann; Nikolaus Behr; André Maier; Thomas Meyer; Patrick Weydt; Harald PrüssShow moreShow less
1. Department of Neurology and Experimental Neurology, Charité –Universitätsmedizin Berlin, Berlin, Germany; 2. German Center for Neurodegenerative Diseases E.V. (DZNE) Berlin, Berlin, Germany; 3. German Center for Neurodegenerative Diseases E.V. (DZNE) Bonn, Bonn, Germany; 4. Institute of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany; 5. ALS and Motoneuron Disease Outpatient Clinic, Charité –Universitätsmedizin Berlin, Berlin, Germany; 6. Motoneuron Disease Outpatient Clinic, Neurozentrum, University Hospital Bonn, Bonn, GermanyShow moreShow less
FAQ
How long does Trials take to review a manuscript?
As of 2026-11-19, CrushSCI has 21 complete review records for Trials. The fastest paper went from submission to acceptance in 127 days (The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) trial—rationale for the selected lower steroid dose, received 2026-03-06, accepted 2026-07-11); the slowest took 603 days. The average is 319.4 days and the median is 244 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
